Kristen Fortney is the CEO and co-founder of BioAge Labs, a startup that leverages artificial intelligence and machine learning to find anti-aging drugs.
Jean Hebert is a professor of neurogenetics at the Albert Einstein College of Medicine and author of the book "Replacing Aging". He is currently developing an approach to reverse aging in the brain by progressive replacement of neural tissue.
Yuva Biosciences is an early stage biotech company attempting to reverse aging by targeting mitochondrial dysfunction.
Maximon is a Swiss longevity venture building company. They partner with entrepreneurs to build longevity-focussed companies from scratch.
Daniel Ives is the founder of Shift Bioscience, a longevity biotech company that targeting aging from mitochondrial DNA dysfunction and epigenetic screens.
Longevitytech.fund is a longevity-focussed venture capital firm based in the Czech Republic. In this episode we discuss their investment philosophy and views on the growing longevity economy.